22 - COVID vaccines: real life experience

Thursday, September 30, 2021

12:30 PM - 1:45 PM EDT

Moderator(s)

Kathleen Neuzil, MD, MPH, FIDSA, FACP

Director of the Center for Vaccine Development and Global Health
University of Maryland
Baltmore, Maryland, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Nadine Rouphael, MD

Professor of Medicine- Director of the Hope Clinic
Emory University
Atlanta, GA, United States

Lilly (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Merck (Individual(s) Involved: Self): Emory study PI, Grant/Research Support; Pfizer: I conduct as co-PI the RSV PFIZER study at Emory, Research Grant; Pfizer (Individual(s) Involved: Self): Grant/Research Support, I conduct as co-PI the RSV PFIZER study at Emory; Quidel (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Sanofi Pasteur (Individual(s) Involved: Self): Chair phase 3 COVID vaccine, Grant/Research Support

Speaker(s)

Emmanuel Mugisha

Senior technical advisor for immunizations
PATH
Kampala, Uganda

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Manjusha Gaglani, MBBS

Director, Center for Research in Vaccines and Infections (CRVI)
Baylor Scott & White Health, Texas A&M University COM, Temple Texas
Temple, TX, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rita Helfand, MD

Senior Adv for Science, Natl Ctr Emerging and Zoonotic Infectious DIseases
CDC
Atlanta, GA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Zanthia Wiley, MD

Associate Professor of Medicine
Emory University
Atlanta, GA, United States

Association of American Medical Colleges (Individual(s) Involved: Self): Consultant; WebMD Health Corporation (Individual(s) Involved: Self): Advisor or Review Panel member

Participants should be aware of the following financial/non-financial relationships:

Kathleen M. Neuzil, MD, MPH, FIDSA, FACP: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Nadine Rouphael, MD: Lilly (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Merck (Individual(s) Involved: Self): Emory study PI, Grant/Research Support; Pfizer: I conduct as co-PI the RSV PFIZER study at Emory, Research Grant; Pfizer (Individual(s) Involved: Self): Grant/Research Support, I conduct as co-PI the RSV PFIZER study at Emory; Quidel (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Sanofi Pasteur (Individual(s) Involved: Self): Chair phase 3 COVID vaccine, Grant/Research Support

Emmanuel Mugisha: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Manjusha Gaglani, MBBS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rita Helfand, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Zanthia Wiley, MD: Association of American Medical Colleges (Individual(s) Involved: Self): Consultant; WebMD Health Corporation (Individual(s) Involved: Self): Advisor or Review Panel member

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the safety and effectiveness of approved/authorized SARS CoV-2 vaccines
identify the delivery challenges of COVID-19 vaccines
address the factors of vaccine hesistancy

Presentations:

COVID-19 Vaccine delivery experiences in Uganda
Speaker: Emmanuel Mugisha – PATH
Effectiveness of SARS-CoV-2 Vaccines in the United States
Speaker: Manjusha Gaglani, MBBS – Baylor Scott & White Health, Texas A&M University COM, Temple Texas
Safety of SARS CoV-2 vaccines: A Global Perspective
Speaker: Rita Helfand, MD – CDC
Vaccine Hesitancy
Speaker: Zanthia Wiley, MD – Emory University